Arsenal announces the sale of Certara, the global leader in model-informed (in silico) drug development and regulatory science, focused on optimizing drug development and improving health outcomes
Arsenal today completed the previously announced sale of its portfolio company Flowchem, a leading manufacturer of pipeline performance products, to KMG, a global provider of specialty chemicals, for $495 million.
KMG, a global provider of specialty chemicals, today announced it has signed a definitive agreement to acquire Flowchem, a leading manufacturer of pipeline performance products, from Arsenal.
